AustralieFrV1, Main, Exploration, bibRecord, 00B926

Anti-Thrombotic, anti-platelet and fibrinolytic therapy: Current management of acute myocardial infarction

Identifieur interne : 00B926 ( Main/Exploration ); précédent : 00B925; suivant : 00B927

Anti-Thrombotic, anti-platelet and fibrinolytic therapy: Current management of acute myocardial infarction

Auteurs : Gérard Helft [France] ; Stephen G. Worthley [Australie]

Source :

Heart, Lung and Circulation [ 1443-9506 ] ; 2001.

RBID : ISTEX:3F2FDB95BBC3071BF2BDCD8BA0B571AB7E07F720

English descriptors

Abstract

Abstract: Significant advances in the treatment of patients with acute myocardial infarction (MI) have been obtained in recent times. In particular, thrombolytic therapy has been shown to preserve ventricular function and improve survival in patients with acute MI. Therapies now include third-generation thrombolytic agents, percutaneous transluminal coronary angioplasty (PTCA) and intracoronary stenting, and new anti-thrombotic therapies including anti-platelet treatment with glycoprotein (GP) IIb/IIIa inhibition and direct anti-thrombin agents. This review will focus on the use of GP IIb/IIIa antagonists and thrombin inhibitors as adjunctive therapies to thrombolytic treatment of patients with acute MI.

Url:

https://api.istex.fr/document/3F2FDB95BBC3071BF2BDCD8BA0B571AB7E07F720/fulltext/pdf

DOI: 10.1046/j.1444-2892.2001.00086.x

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 000B80
to stream Istex, to step Curation: 000B80
to stream Istex, to step Checkpoint: 001D30
to stream Main, to step Merge: 00C771
to stream Main, to step Curation: 00B926

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Anti-Thrombotic, anti-platelet and fibrinolytic therapy: Current management of acute myocardial infarction</title>
<author><name sortKey="Helft, Gerard" sort="Helft, Gerard" uniqKey="Helft G" first="Gérard" last="Helft">Gérard Helft</name>
</author>
<author><name sortKey="Worthley, Stephen G" sort="Worthley, Stephen G" uniqKey="Worthley S" first="Stephen G." last="Worthley">Stephen G. Worthley</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3F2FDB95BBC3071BF2BDCD8BA0B571AB7E07F720</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1046/j.1444-2892.2001.00086.x</idno>
<idno type="url">https://api.istex.fr/document/3F2FDB95BBC3071BF2BDCD8BA0B571AB7E07F720/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B80</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B80</idno>
<idno type="wicri:Area/Istex/Curation">000B80</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D30</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D30</idno>
<idno type="wicri:doubleKey">1443-9506:2001:Helft G:anti:thrombotic:anti</idno>
<idno type="wicri:Area/Main/Merge">00C771</idno>
<idno type="wicri:Area/Main/Curation">00B926</idno>
<idno type="wicri:Area/Main/Exploration">00B926</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Anti-Thrombotic, anti-platelet and fibrinolytic therapy: Current management of acute myocardial infarction</title>
<author><name sortKey="Helft, Gerard" sort="Helft, Gerard" uniqKey="Helft G" first="Gérard" last="Helft">Gérard Helft</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Clinique Cardiologique-Adultes, Hùpital Necker, Assistance Publique, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Worthley, Stephen G" sort="Worthley, Stephen G" uniqKey="Worthley S" first="Stephen G." last="Worthley">Stephen G. Worthley</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Correspondence: Stephen G. Worthley, Cardiovascular Research Centre, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168</wicri:regionArea>
<wicri:noRegion>Victoria 3168</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Cardiovascular Research Centre, Monash Medical Centre, Clayton, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Australie</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Heart, Lung and Circulation</title>
<title level="j" type="abbrev">HLC</title>
<idno type="ISSN">1443-9506</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">10</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="68">68</biblScope>
<biblScope unit="page" to="74">74</biblScope>
</imprint>
<idno type="ISSN">1443-9506</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1443-9506</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abciximab</term>
<term>Activator</term>
<term>Adjunctive</term>
<term>Adjunctive heart</term>
<term>Adjunctive therapies</term>
<term>Alteplase</term>
<term>Angioplasty</term>
<term>Clinical trials</term>
<term>Coronary arteries</term>
<term>Fibrinolysis</term>
<term>Fibrinolytic</term>
<term>Fibrinolytic agents</term>
<term>Helft</term>
<term>Heparin</term>
<term>Hirudin</term>
<term>Infarction</term>
<term>Inhibitor</term>
<term>Intravenous</term>
<term>Intravenous heparin</term>
<term>Intravenous streptokinase</term>
<term>Mortality rate</term>
<term>Myocardial</term>
<term>Myocardial infarction</term>
<term>Patency</term>
<term>Plasminogen</term>
<term>Platelet</term>
<term>Platelet activation</term>
<term>Platelet aggregation</term>
<term>Preliminary results</term>
<term>Procoagulant activity</term>
<term>Randomised</term>
<term>Randomized</term>
<term>Randomized trial</term>
<term>Receptor</term>
<term>Recombinant</term>
<term>Recombinant hirudin</term>
<term>Reperfusion</term>
<term>Streptokinase</term>
<term>Thrombin</term>
<term>Thrombin inhibitors</term>
<term>Thrombolysis</term>
<term>Thrombolytic</term>
<term>Thrombolytic agents</term>
<term>Thrombolytic therapy</term>
<term>Thrombus</term>
<term>Timi</term>
<term>Tissue plasminogen activator</term>
<term>Worthley</term>
<term>Worthley fibrinolysis</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abciximab</term>
<term>Activator</term>
<term>Adjunctive</term>
<term>Adjunctive heart</term>
<term>Adjunctive therapies</term>
<term>Alteplase</term>
<term>Angioplasty</term>
<term>Clinical trials</term>
<term>Coronary arteries</term>
<term>Fibrinolysis</term>
<term>Fibrinolytic</term>
<term>Fibrinolytic agents</term>
<term>Helft</term>
<term>Heparin</term>
<term>Hirudin</term>
<term>Infarction</term>
<term>Inhibitor</term>
<term>Intravenous</term>
<term>Intravenous heparin</term>
<term>Intravenous streptokinase</term>
<term>Mortality rate</term>
<term>Myocardial</term>
<term>Myocardial infarction</term>
<term>Patency</term>
<term>Plasminogen</term>
<term>Platelet</term>
<term>Platelet activation</term>
<term>Platelet aggregation</term>
<term>Preliminary results</term>
<term>Procoagulant activity</term>
<term>Randomised</term>
<term>Randomized</term>
<term>Randomized trial</term>
<term>Receptor</term>
<term>Recombinant</term>
<term>Recombinant hirudin</term>
<term>Reperfusion</term>
<term>Streptokinase</term>
<term>Thrombin</term>
<term>Thrombin inhibitors</term>
<term>Thrombolysis</term>
<term>Thrombolytic</term>
<term>Thrombolytic agents</term>
<term>Thrombolytic therapy</term>
<term>Thrombus</term>
<term>Timi</term>
<term>Tissue plasminogen activator</term>
<term>Worthley</term>
<term>Worthley fibrinolysis</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Significant advances in the treatment of patients with acute myocardial infarction (MI) have been obtained in recent times. In particular, thrombolytic therapy has been shown to preserve ventricular function and improve survival in patients with acute MI. Therapies now include third-generation thrombolytic agents, percutaneous transluminal coronary angioplasty (PTCA) and intracoronary stenting, and new anti-thrombotic therapies including anti-platelet treatment with glycoprotein (GP) IIb/IIIa inhibition and direct anti-thrombin agents. This review will focus on the use of GP IIb/IIIa antagonists and thrombin inhibitors as adjunctive therapies to thrombolytic treatment of patients with acute MI.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Helft, Gerard" sort="Helft, Gerard" uniqKey="Helft G" first="Gérard" last="Helft">Gérard Helft</name>
</region>
</country>
<country name="Australie"><noRegion><name sortKey="Worthley, Stephen G" sort="Worthley, Stephen G" uniqKey="Worthley S" first="Stephen G." last="Worthley">Stephen G. Worthley</name>
</noRegion>
<name sortKey="Worthley, Stephen G" sort="Worthley, Stephen G" uniqKey="Worthley S" first="Stephen G." last="Worthley">Stephen G. Worthley</name>
<name sortKey="Worthley, Stephen G" sort="Worthley, Stephen G" uniqKey="Worthley S" first="Stephen G." last="Worthley">Stephen G. Worthley</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B926 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00B926 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:3F2FDB95BBC3071BF2BDCD8BA0B571AB7E07F720
   |texte=   Anti-Thrombotic, anti-platelet and fibrinolytic therapy: Current management of acute myocardial infarction
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Anti-Thrombotic, anti-platelet and fibrinolytic therapy: Current management of acute myocardial infarction

Anti-Thrombotic, anti-platelet and fibrinolytic therapy: Current management of acute myocardial infarction

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri